Recent Updates — CHE

Chemed Corporation reported third-quarter results ending September 30, 2026, with consolidated revenue increasing 10.6% to $690.9 million. GAAP diluted earnings per share rose 22.2% to $5.45, while adjusted diluted EPS increased 28.1% to $6.75. The VITAS hospice segment drove growth with net patient revenue up 12.2% to $457.4 million and average daily census rising 9.4%. Roto-Rooter plumbing services saw revenue grow 7.5% to $233.5 million, though adjusted EBITDA declined slightly by 2.5%. The company also repurchased 125,000 shares for $66.0 million and updated full-year guidance to be at or above the high-end of previous estimates. Chemed operates in the healthcare field through its VITAS Healthcare Corporation subsidiary providing end-of-life care, and in the residential and commercial plumbing industry under the Roto-Rooter brand.

Chemed Corporation reported second-quarter 2026 financial results, with consolidated revenue increasing 8.8% to $673.3 million and GAAP diluted EPS rising 43.7% to $5.13. The VITAS segment drove growth, posting an 11.9% increase in net patient revenue to $443.3 million and a 60.5% surge in net income to $61.3 million, while Roto-Rooter revenue grew 3.3% to $229.9 million. The company updated its full-year 2026 adjusted EPS guidance upward to a range of $25.00 to $25.75, reflecting VITAS outperformance and share repurchases. Chemed repurchased 210,000 shares for $89.8 million during the quarter and maintains $140.0 million in long-term debt under a new $450 million credit facility. Chemed operates in the healthcare and home services industries through its VITAS hospice care and Roto-Rooter plumbing subsidiaries.